Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Millikan

Showing results (111-120 of 184) with videos related to

Pageof 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistanceDonal J Brennan, Karin Jirstrom, Asa Kronblad, et al.
American Journal of Epidemiology|July 1, 2008
Consumption of trans-fatty acid and its association with colorectal adenomasLisa C Vinikoor, Jane C Schroeder, Robert C Millikan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 1998
Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer riskR C Millikan, G S Pittman, B Newman, et al.
The Journal of Investigative Dermatology|May 14, 2004
Tandem BRAF mutations in primary invasive melanomasNancy E Thomas, Audrey Alexander, Sharon N Edmiston, et al.
Breast Cancer Research : BCR|February 2, 2011
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifenDonal J Brennan, Henriette Laursen, Darran P O'Connor, et al.
Carcinogenesis|December 17, 1998
Catechol-O-methyltransferase and breast cancer riskR C Millikan, G S Pittman, C K Tse, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 1994
Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistryC M Lyles, R S Sandler, T O Keku, et al.
Frontiers in Oncology|June 1, 2012
RASSF1A and the rs2073498 Cancer Associated SNPHoward Donninger, Thibaut Barnoud, Nick Nelson, et al.
Breast Cancer Research : BCR|November 11, 2005
The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based studyKathleen Conway, Eloise Parrish, Sharon N Edmiston, et al.
Disease Markers|March 2, 2012
IGF2R genetic variants, circulating IGF2 concentrations and colon cancer risk in African Americans and WhitesCathrine Hoyo, Susan K Murphy, Joellen M Schildkraut, et al.
Pageof 19

Showing results (111-120 of 184) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistanceDonal J Brennan, Karin Jirstrom, Asa Kronblad, et al.
American Journal of Epidemiology|July 1, 2008
Consumption of trans-fatty acid and its association with colorectal adenomasLisa C Vinikoor, Jane C Schroeder, Robert C Millikan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 1998
Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer riskR C Millikan, G S Pittman, B Newman, et al.
The Journal of Investigative Dermatology|May 14, 2004
Tandem BRAF mutations in primary invasive melanomasNancy E Thomas, Audrey Alexander, Sharon N Edmiston, et al.
Breast Cancer Research : BCR|February 2, 2011
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifenDonal J Brennan, Henriette Laursen, Darran P O'Connor, et al.
Carcinogenesis|December 17, 1998
Catechol-O-methyltransferase and breast cancer riskR C Millikan, G S Pittman, C K Tse, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 1994
Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistryC M Lyles, R S Sandler, T O Keku, et al.
Frontiers in Oncology|June 1, 2012
RASSF1A and the rs2073498 Cancer Associated SNPHoward Donninger, Thibaut Barnoud, Nick Nelson, et al.
Breast Cancer Research : BCR|November 11, 2005
The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based studyKathleen Conway, Eloise Parrish, Sharon N Edmiston, et al.
Disease Markers|March 2, 2012
IGF2R genetic variants, circulating IGF2 concentrations and colon cancer risk in African Americans and WhitesCathrine Hoyo, Susan K Murphy, Joellen M Schildkraut, et al.
Pageof 19